Miranda Hoffman v. HHS - Meningococcal, Guillain–Barré syndrome (“GBS”) (2014)

Miranda Hoffman filed a petition on November 20, 2014, seeking compensation under the National Vaccine Injury Compensation Program. She alleged that she suffered from Guillain-Barré syndrome (GBS) as a result of receiving the Meningococcal Conjugate (Menectra) vaccine on January 20, 2012, and experienced residual effects for more than six months.

The respondent denied that the vaccine caused her GBS or any other injury. However, both parties agreed to settle the case through a stipulation.

The stipulation included an award of $350,000.00 for all damages, payable to Petitioner, and $18,693.49 for attorneys' fees and costs, payable jointly to Petitioner and her attorney, M. Clay Ragsdale, Esq.

Special Master Brian H. Corcoran reviewed the stipulations and found them reasonable, adopting them as the decision of the court.

Judgment was to be entered accordingly.